Trial to Evaluate L9LS in Healthy Adults

NCT05019729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

DRUG: VRC-MALMAB0114-00-AB
OTHER: Plasmodium falciparum (P. falciparum) sporozoite challenge

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)